News
MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.
Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback